netFormulary NHS
Isle of Wight
Formulary
 Search
 Formulary Chapter 9: Nutrition and blood - Full Chapter
Chapter Links...
 Details...
09.01  Expand sub section  Anaemias and some other blood disorders
09.01.01  Expand sub section  Iron-deficiency anaemias
09.01.01.01  Expand sub section  Oral iron
 note 

Combination products and modified release products are not recommended for prescribing on NHS

Ferrous Fumarate
View adult BNF View SPC online View childrens BNF
First Choice
Green
Strength (Brand) Dose Elemental iron content
210mg

1 BD-TDS (Treatment)

1 OD-BD (maintenance)

68mg/ tablet
305mg (Galfer)

1 BD (Treatment)

1 OD (maintenance)

100mg/ capsule
322mg (Fersaday)

1 BD (Treatment)

1 OD (maintenance)

100mg / tablet
140mg/5ml solution

10ml BD (Treatment)

5ml OD (Maintenance)

45mg / 5ml

Combination products with ascorbic acid and modified release products are not recommended for prescribing on NHS

 
Ferrous Sulphate
View adult BNF View SPC online View childrens BNF
Second Choice
Green
 
Ferrous Gluconate
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
Sodium Feredetate
(Sytron®)
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
09.01.01.02  Expand sub section  Parenteral iron
Ferric Carboxymaltose
(Ferinject®) Black Triangle
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Iron Dextran (CosmoFer®) Black Triangle
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Iron Isomaltoside
(Monofer®) Black Triangle
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
Iron Sucrose (Venofer®) Black Triangle
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
09.01.02  Expand sub section  Drugs used in megaloblastic anaemias to top
Hydroxocobalamin
(Vitamin B12)
View adult BNF View SPC online View childrens BNF
Formulary
Green

During the COVID-19 pandemic please consider the need for vitamin B12 injections and advise patients to buy supplements over the counter to reduce patient contacts and support social distancing measures.

Ensure the patient has a follow up blood test in the future to identify any that have asoprtion issues.

 
Link  Oral vitamin B12 – what are the prescribing considerations and what formulations are available?
Link  Vitamin B12 Information Leaflet
Link  Vitamin B12 Supplement Algorithm
Folic Acid
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
Cyanocobalamin
View adult BNF View SPC online View childrens BNF
Formulary
Green

50mcg tablets are the only licensed oral preparation.

Please see IoW CCG vitamins guidance for more info.

GP- GREY LIST

 
Link  Oral vitamin B12 – what are the prescribing considerations and what formulations are available?
09.01.03  Expand sub section  Drugs used in hypoplastic, haemolytic, and renal anaemias
09.01.03  Expand sub section  Erythropoietin
Darbepoetin Alfa
(Aranesp®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
 
Epoetin alfa (Eprex®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
 
Epoetin beta
(NeoRecormon®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
 
Epoetin Zeta (Retacrit®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
 
09.01.03  Expand sub section  Iron overload
09.01.04  Expand sub section  Drugs used in autoimmune thrombocytopenic purpura
Eltrombopag
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
 
Link  Interim Clinical Commissioning Policy: Thrombopoietin receptor agonists as first line therapy for new or relapsed immune thrombocytopenia in adults and children over the age of 1 year during the COVID-19 pandemic
Link  NICE TA293: Eltrombopag for treating chronic ITP
Romiplostim (Nplate®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
 
Link  Interim Clinical Commissioning Policy: Thrombopoietin receptor agonists as first line therapy for new or relapsed immune thrombocytopenia in adults and children over the age of 1 year during the COVID-19 pandemic
Link  NICE TA221: Thrombocytopenic purpura - romiplostim
09.01.05  Expand sub section  G6PD deficiency to top
09.01.06  Expand sub section  Drugs used in neutropenia
Filgrastim
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
 
09.01.07  Expand sub section  Drugs used to mobilise stem cells
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Green

Drugs that may be initiated, stabilised and maintained by primary, secondary or tertiary care Secondary and tertiary care prescribing may be continued by primary care. [this does not indicate first/second line choice]  

Green Hospital

Items used by the Hospital but would not normally be continued into primary care. Primary care prescribers can change to GREEN first or second.   

Green plus

Initiation of drugs by primary care following written advice from secondary/ tertiary care advice.  

Yellow

Drugs that may be continued in primary care following initiation and stabilisation in secondary/tertiary care  

Amber

Items requiring a shared care agreement. These items should be initiated and stabilised by secondary or tertiary care. The GP should only be asked to take over prescribing through a formal shared care agreement. Secondary care will be expected to continue prescribing until the agreement is made.  

Red

Hospital/ Trust ONLY. These are items the secondary and tertiary care are responsible for prescribing and will need to continue to prescribe for long term maintenance. These items will NOT be prescribed in primary care. But primary care should be informed the patient is receiving these items. This will include NHSE funded items requiring repatriation.  

GP - Black

Items covered by NHSE ‘Should not prescribe in primary care list’ – See CCG policy on Drugs of limited clinical value  

GP - Grey

Grey List: Items covered by NHSE ‘Should not prescribe in primary care list’ that are not to be routinely prescribed but may be suitable in a defined population – See CCG policy on Drugs of limited clinical value  

netFormulary